Ortec Announces Claims Approval

Sep 22, 2006 | Contact Author | By: Katie Schaefer
Contact the Author
Save
This item has been saved to your library.
View My Library
(click to close)
Save to My Library
Title: Ortec Announces Claims Approval
  • Article
Ortec International Inc. has announced that the US Patent and Trademark Office (USPTO) has approved claims for the second patent application of its Haptides technology platform. "This represents the second patent to be granted in the US covering the Haptides technology, a versatile technology which we believe can improve the efficacy of an array of current biomaterials in the market place today. We are actively pursuing licensing opportunities with this proprietary peptide with companies focused on the orthopedic, dental, and cosmetic markets, and we believe the newly granted claims further enhance Haptides’ potential value,” commented Ortec's Vice Chairman and CEO Ron Lipstein.